Cancer in pregnancy GL - ESGO Gynae-Oncology Guidelines Skip to content

ESGO-INCIP Guidelines for the management of pregnant patients with gynaecological cancers

In 2024, the ESGO and INCIP (International Network on Cancer, Infertility and Pregnancy) initiated the development of the guidelines for the management of pregnant patients with gynaecological cancers. The multidisciplinary team of experts specialized in gynaecological oncology, obstetrics, pediatrics, perinatology, neonatology, epidemiology, medical oncology, radiotherapy, sonography including two patients represenatives, was led by Prof. Frédéric Amant (ESGO) and Prof. Michael Halaska (INCIP) and have developed the evidence-based guidelines and clinical decision trees.

The article is expected to be published in Q2 2025.

Working group

Expert Country Institution
Frédéric Amant Belgium Division Gynecologic Oncology, UZ Leuven, Belgium
Michael Halaska Czech Republic Department of Obstetrics and Gynaecology, 3rd Medical Faculty, Charles University in Prague
University Hospital Kralovske Vinohrady
Prague, Czech Republic
Francois Planchamp France Institut Bergonié, Bordeaux, France
Indra Anna Van Assche Belgium Development and Regeneration, KU Leuven, Belgium
Paul Berveiller France Department of Obstetrics and gynecology, Poissy-Saint Germain Hospital, Poissy, France
Université Paris-Saclay, UVSQ, INRAE, BREED - 78350, Jouy-en-Josas, France
Kristel Van Calsteren Belgium Department of Gynaecology and Obstetrics, UZ Leuven, Belgium
Elyce Cardonick United States  Obstetrics and Gynecology,  Cooper University Hospital, United States of America
Robert Fruscio Italy Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy
UO Gynecology, IRCCS San Gerardo dei Tintori, Monza, Italy.
Monica Fumagalli Italy NICU Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
University of Milan. Department of Clinical Sciences and Community Health
Anna Johansson Sweden  Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden
Matteo Lambertini Italy Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa, Italy
Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
Charlotte Lejeune Belgium Division Gynecologic Oncology, UZ Leuven, Belgium
Christianne Lok the Netherlands Department of gynaecologic oncology, Center of Gynaecologic Oncology Amsterdam, The Netherlands
Glenn W McCluggage United Kingdom Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom
Anne De Middelaer Belgium ENGAGe
Philip Poortmans Belgium Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium
University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium
Jacek Sienko Poland 2nd Department of Obstetrics and Gynecology,  Medical University of Warsaw
Cristel Maria  Sørensen Hjortshøj Denmark Department of Pediatric cardiology, Copenhagen University Hospital, Denmark
Marta Swierczynska Poland
Antonia Testa Italy Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Department of Life Science and Public Health, Catholic University of Sacred Heart Largo Agostino Gemelli, Rome, Italy
Vincent Vandecaveye Belgium Department of Radiology, University Hospitals Leuven, Belgium
Carolien Versteeg the Netherlands ENGAGe
Flora Zagouri Greece Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra Hospital
Ignacio Zapardiel Spain Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain

External reviewers

102 reviewers - 32 countries

ESGO would also like to thank external reviewers who have taken the time to provide their feedback on the document elaborated in the framework of the ESGO-INCIP Guidelines for the management of pregnant patients with gynaecological cancers.

List of external reviewers